Mammography may be beneficial to all women, regardless of ageApril 22, 2008HOUSTON - According to researchers at The University of Texas M. D. Anderson Cancer Center, mammography, the gold-standard for breast cancer screening and early detection, has shown to significantly reduce the risk of being diagnosed with advanced stage breast cancer in women over the age of 80, an age group currently without clear guidelines recommending regular screenings. The study, published online today (April 21) in the Journal of Clinical Oncology (JCO), is the first to specifically assess the screening modality in women older than 80. It's estimated that approximately 17 percent of breast cancers are diagnosed in women older than 80, and only about one-fifth of women in this age group have routine mammograms. According to the study's senior author, Gildy Babiera, M.D., the need for this study evolved as she began to notice a growing number of women who were 80-years-old and older in her clinic.
"With an increasing number of people living longer, there's a real dilemma regarding how best to manage the care of breast cancer patients 80 years of age and older, taking into account both their comorbidities and their account their quality of life," said Babiera, associate professor in the Department of Surgical Oncology. This research follows other M. D. Anderson studies looking at complications associated with surgery and treatment tolerability in elderly patients. The American Cancer Society recommends annual mammography screening for women starting at age 40 with no age limit for women in good health. Other organizations that recommend screening guidelines differ both in age ceilings as well as how often mammograms should be conducted in older women. Babiera, Brian Badgwell, M.D., a fellow in M. D. Anderson's Department of Surgical Oncology, and their colleagues used information from the National Cancer Institute SEER (Surveillance, Epidemiology, and End Results) database, the authoritative source of information on cancer incidence and survival in the United States. The researchers analyzed SEER data for the years 1996-2002, and looked at mammography rates in the five years prior to diagnosis. In total, 12,358 women over age 80 were analyzed. Patients were stratified into nonusers (women who did not have mammograms), 49 percent; irregular users (women who had one or two mammograms), 29 percent; and regular users (women who had three or more mammograms.), 22 percent. Sixty-eight percent of regular users were more likely to be diagnosed with early disease, stage I while nonusers and irregular users more often were diagnosed with stages II, III or IV, 56 percent and 33 percent respectively. Five-year survival rate was 94 percent in regular users, compared to 88 percent in irregular users and 82 percent in nonusers. Despite these rates, the researchers were not able to find an increase in overall survival because those getting mammograms were healthier and, therefore, more likely to live longer, said Badgwell, the study's first author. "For example, in our study, we showed a 12 percent decrease in the risk of breast cancer death for each mammogram. However, in the women who received mammograms, we also showed a 12 percent decrease in non-breast cancer death, thereby showing the bias for women who were healthy and receiving mammograms," said Badgwell. Babiera and Badgwell acknowledge their studies limitations but feel this type of retrospective data may be the best that can be obtained because it's unlikely a randomized control trial could ever be conducted. "Now that we have this data and we know that mammography improves survival in the younger population, it would be difficult to conduct a randomized trial and stratify women of any age to a control group to not receive mammography," said Badgwell. Instead, the researchers stress that physicians should review each woman's situation personally to determine if a mammogram is in her best interest, and if she is found to have breast cancer, could her quality of life be managed appropriately. "Finding breast cancer early in this age group may not result in survival benefit and it may even increase unnecessary angst in elderly women with other ailments. On the other hand, if the woman is otherwise healthy and could be a surgical candidate, should breast cancer be found by a routine mammogram, perhaps she could be offered less invasive treatment and spared from toxic therapies given to women diagnosed with advanced breast cancer," said Babiera. University of Texas M. D. Anderson Cancer Center | |||||||||||||||||||||
|
Related Breast Cancer News Articles M. D. Anderson study finds change in HER2 status after treatment with Herceptin Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. M. D. Anderson study finds racial disparities in radiation therapy rates for breast cancer Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. New nano device detects immune system cell signaling Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances. CSHL scientists identify new drug target against virulent type of breast cancer Tumor cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 -- also often called HER2 -- which drives the cells to proliferate unchecked. Patients unlucky enough to be in this group -- about one in four -- have poorer prognoses and clinical outcomes than those who don't. Dense tissue promotes aggressive cancers New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. Women exposed to negative life events at greater risk of breast cancer: BGU study Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease. Hormone replacement therapy improves sleep, sexuality and joint pain in older women One of the world's longest and largest trials of hormone replacement therapy (HRT) has found that post-menopausal women on HRT gain significant improvements in quality of life. Positive thinking may protect against breast cancer Feelings of happiness and optimism play a positive role against breast cancer. Research published today in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease. Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1 Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered. Why a common treatment for prostate cancer ultimately fails Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. More Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||